Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
Danilo De Gregorio(University of Campania "Luigi Vanvitelli"), Gabriella Gobbi(McGill University), Matthew Kaba Aboud(McGill University), Luca Posa(Montreal Neurological Institute and Hospital), Justine P. Enns(McGill University), Sabatino Maione(University of Campania "Luigi Vanvitelli"), Ryan J. McLaughlin(Washington State University), Martha López-Canul(Montreal Neurological Institute and Hospital), Rafael Ochoa‐Sanchez(Montreal Neurological Institute and Hospital), Stefano Comai(University of Padua)
Cited by 395
Related Papers
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
|Pharmacological Reviews|2018|386
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
|Nature Neuroscience|2006|373
Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex
|Journal of Neuroscience|2007|327